CorMedix (CRMD) Stock Research, Analysis & News
Quick Analysis on CorMedix (CRMD) Stock as of April 20, 2018
 | The Stock pays no dividend |
 | Average trading volume is relatively low at 0 |
(See more information about CorMedix (CRMD) Stock below)
CorMedix (CRMD) Stock Profile Summary
CorMedix, Inc., a development-stage biopharmaceutical company, develops, manufactures, and markets products that lock a patient's central venous catheter between hemodialysis sessions to keep it free of infection and clots. It provides CMX001 that reduces oxidative stress due to excess labile iron; CMX002, a diagnostic test for chronic kidney disease; CMX003, an antimicrobial/anticoagulant solution; and CMX004, a pressure-sensitive gel. The company was incorporated in 2006 and is based in Bridgewater, New Jersey.
CorMedix (CRMD) Stock Key Statistics Research and Analysis as of April 20, 2018
CorMedix (CRMD) Stock Competitor Research and Analysis
Stock Research on CorMedix (CRMD)
Latest Market News on CorMedix (CRMD)
Click here to find the latest news on CorMedix (CRMD)
Looking for Market Opportunties?
Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center
See other companies in the same industry
Amgen Inc. (AMGN) Biogen Idec Inc. (BIIB) Genzyme Corp. (GENZ) Gilead Sciences Inc. (GILD) Life Technologies Corporation (LIFE) Teva Pharmaceutical Industries Limited (TEVA) Watson Pharmaceuticals Inc. (WPI) King Pharmaceuticals Inc. (KG) Mylan, Inc. (MYL) Pfizer Inc. (PFE) Johnson & Johnson (JNJ) GlaxoSmithKline plc (GSK) Sanofi-Aventis (SNY) Novartis AG (NVS) AstraZeneca PLC (AZN) Abbott Laboratories (ABT) Bristol-Myers Squibb Company (BMY)
Research on CorMedix (CRMD)
